Cabaletta Bio Receives FDA Clearance of IND Application for CABA-201 for Treatment of…
<!-- Name:DistributionId Value:8799423 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Browsing Tag
Erythematosus
Vera Therapeutics Announces Two Oral Presentations at the 59th European Renal…
BRISBANE, Calif., May 03, 2022 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late-stage biotechnology company focused on developing and commercializing transformative…
Systemic Lupus Erythematosus Pipeline Insights | Research Report 2022 by DelveInsight
Las Vegas, USA, Feb. 09, 2022 (GLOBE NEWSWIRE) -- Systemic Lupus Erythematosus Pipeline Insights | Research Report 2022 by DelveInsight Systemic Lupus Erythematosus pipeline…
DelveInsight Analyzes a Thriving Cutaneous Lupus Erythematosus Pipeline in the Coming…
Las Vegas, USA, Oct. 27, 2021 (GLOBE NEWSWIRE) -- DelveInsight Analyzes a Thriving Cutaneous Lupus Erythematosus Pipeline in the Coming Years as Key Pharma Companies Enter the Sphere…
Landos Biopharma Announces FDA Clearance of its IND for LABP-104 for the Treatment of…
Phase 1 trial initiation expected before yearend with topline results in 1H 2022 BLACKSBURG, Va., Oct. 11, 2021 (GLOBE NEWSWIRE) -- Landos Biopharma, Inc. (NASDAQ: LABP), a late…